Haniva was awarded a US Patent In March, 2017 for the Combination Therapy of non-thermal plasma and any DNA damaging agent activated by hypoxia (Patent number 9,586,056). As of May, 2021, they also received patent approval for their combination therapy from the Australian government.
Acclinate
1 follower
Thermo Fisher Scientific
284 followers
Genentech
226 followers
Gilead Sciences
213 followers
Regeneron
181 followers
Biogen
165 followers
Vertex Pharmaceuticals
111 followers
Agilent Technologies
101 followers
BioMarin Pharmaceutical
59 followers
Alexion Pharmaceuticals
56 followers
Myriad Genetics
42 followers
Bio-Rad Laboratories
34 followers